≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Degenerative conditions of globe

DOID EFO Endpoint Browser PheWeb

H7_GLOBEDEGENERATED

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H44.5
  • Hospital discharge: ICD-9 — 3604
  • Hospital discharge: ICD-8 — 37861|37514
  • Cause of death: ICD-10 — H44.5
  • Cause of death: ICD-9 — 3604
  • Cause of death: ICD-8 — 37861|37514

2 out of 7 registries used, show all original rules.

195

4. Check minimum number of events

None

195

5. Include endpoints

None

195

6. Filter based on genotype QC (FinnGen only)

195

Control definitions (FinnGen only)

Control exclude
H7_VITREOUS

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H44
Name in latin
Degeneratio bulbi oculi

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3241 1579 1622
Only index persons 2177 1098 1079
Unadjusted period prevalence (%)
Whole population 0.05 0.05 0.05
Only index persons 0.04 0.04 0.04
Median age at first event (years)
Whole population 71.66 76.48 66.95
Only index persons 69.72 76.15 63.17

-FinnGen-

Key figures

All Female Male
Number of individuals 195 71 124
Unadjusted period prevalence (%) 0.04 0.02 0.05
Median age at first event (years) 65.99 65.20 66.44

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
177
Matched controls
1768
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H44.5
ICD-10 Finland
Degenerated conditions of globe
+∞
190.9
147
*
114
Kela drug reimbursment
Glaucoma
20.1
59.4
100
107
S01ED51
ATC
timolol, combinations; ophthalmic
21.2
54.6
87
77
S01ED01
ATC
timolol; ophthalmic
21.6
42.7
65
46
S01EC01
ATC
acetazolamide; systemic
39.2
42.1
53
19
S01EX03
ATC
NA
26.7
40.0
56
30
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
39.6
36.0
45
15
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
116.1
35.3
37
*
S01EE01
ATC
latanoprost; ophthalmic
12.0
28.3
55
64
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
23.4
27.2
39
21
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
249.4
22.1
22
*
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
12.1
21.8
41
43
S01EC03
ATC
dorzolamide; ophthalmic
26.3
21.2
29
13
H43.1
ICD-10 Finland
Vitreous haemorrhage
223.9
20.0
20
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
5.8
19.5
63
153
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
4.4
19.3
107
457
H54.4
ICD-10 Finland
Blindness, monocular
+∞
19.1
18
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
4.4
19.0
105
441
37861
ICD-8 Finland
Other diseases of eye, Phthisis et degeneratio bulbi
+∞
15.9
15
*
H33.0
ICD-10 Finland
Retinal detachment with retinal break
18.3
15.8
24
15
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.2
15.2
52
131
XCK00
NOMESCO Finland
Perimetry
8.2
14.8
34
50
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
87.5
14.8
16
*
CDC00
NOMESCO Finland
Enucleation of eye
+∞
14.8
14
*
CHF15
NOMESCO Finland
Cryotherapy of ciliary body
+∞
14.8
14
*
S01EA02
ATC
dipivefrine; ophthalmic
30.1
14.6
19
7
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
13.0
14.3
25
22
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
9.9
13.9
28
33
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
20.3
13.7
20
11
37520
ICD-8 Finland
Glaucoma, Secondary
+∞
13.7
13
*
S01EC04
ATC
brinzolamide; ophthalmic
10.7
13.5
26
28
S01FA01
ATC
atropine; ophthalmic
31.1
13.2
17
6
S01EB01
ATC
pilocarpine; ophthalmic
15.7
13.1
21
15
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
10.0
13.0
26
30
Z97.0
ICD-10 Finland
Presence of artificial eye
+∞
12.6
12
*
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
139.4
12.6
13
*
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
29.1
12.3
16
6
H43.8
ICD-10 Finland
Other disorders of vitreous body
32.5
11.8
15
5
A10AA01
ATC
NA
15.0
11.8
19
14
37514
ICD-8 Finland
Glaucoma, Chronicum absolutum s. fero absolutum dolorosum
+∞
11.6
11
*
H3603, E103
ICD-10 Finland
NA
127.9
11.6
12
*
25002
ICD-8 Finland
Diabetes mellitus, Retinopathia diabetica
127.9
11.6
12
*
CKD20
NOMESCO Finland
Removal of vitreous body substitute
127.9
11.6
12
*
H54.0
ICD-10 Finland
Blindness, binocular
116.6
10.5
11
*
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
+∞
10.5
10
*
A10AA02
ATC
NA
8.1
10.4
23
32
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
15.8
10.2
16
11
H16.0
ICD-10 Finland
Corneal ulcer
8.2
10.1
22
30
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
11.6
10.0
18
17
H34.8
ICD-10 Finland
Other retinal vascular occlusions
12.4
9.8
17
15
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
11.6
9.5
17
16
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
105.4
9.5
10
*
TCA15
NOMESCO Finland
Retrobulbar therapeutic injection into orbit
+∞
9.5
9
*
3610A
ICD-9 Finland
Retinal detachments and defects, Retinal detachment with retinal defect
+∞
9.5
9
*
3604A
ICD-9 Finland
Disorders of the globe, Degenerated conditions of globe
+∞
9.5
9
*
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
8.5
9.4
20
26
S01EA03
ATC
apraclonidine; ophthalmic
12.4
9.3
16
14
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
38.8
9.1
11
*
H04AA01
ATC
glucagon; nasal, parenteral
15.1
8.8
14
10
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
15.1
8.8
14
10
H40.0
ICD-10 Finland
Glaucoma suspect
5.6
8.7
25
50
CKD15
NOMESCO Finland
Injection of vitreous substitute
94.3
8.5
9
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
13.9
8.0
13
10
H04.10
ICD-10 Finland
Dry eye syndrome
4.7
7.7
26
63
3651A
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]
19.4
7.7
11
6
H26.2
ICD-10 Finland
Complicated cataract
26.3
7.7
10
*
Z94.0
ICD-10 Finland
Kidney transplant status
83.4
7.5
8
*
H54.1
ICD-10 Finland
Severe visual impairment, binocular
83.4
7.5
8
*
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
7.9
7.4
16
22
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
7.1
7.3
17
26
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
6.5
7.3
18
30
S01ED02
ATC
betaxolol; ophthalmic
9.4
7.2
14
16
S01EE05
ATC
tafluprost; ophthalmic
8.8
7.0
14
17
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
11.6
6.9
12
11
127
Kela drug reimbursment
Transplant complication
41.7
6.8
8
*
S01FA02
ATC
scopolamine; ophthalmic
23.5
6.7
9
*
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
12.9
6.7
11
9
S01BC03
ATC
diclofenac; ophthalmic
7.0
6.5
15
23
Z49.1
ICD-10 Finland
Extracorporeal dialysis
18.8
6.3
9
5
3651B
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]
18.8
6.3
9
5
H18.1
ICD-10 Finland
Bullous keratopathy
+∞
6.3
6
*
CDC40
NOMESCO Finland
Evisceration of eye with insertion of prosthesis
+∞
6.3
6
*
3643
FHL
Vitrectomy through pars Plana
+∞
6.3
6
*
CAW99
NOMESCO Finland
Other operation on orbit
+∞
6.3
6
*
CKC20
NOMESCO Finland
Cryopexy of undetached retina
+∞
6.3
6
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
27.7
6.3
8
*
H3603, E113
ICD-10 Finland
NA
27.7
6.3
8
*
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
8.2
6.2
13
17
3626
FHL
Extracapsular cataract surgery and implantation of an artificial lens
5.6
6.2
17
33

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
41
156
3.06
8.37
2.4
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
35
158
2.48
5.07
2.8
6.1
mmol/l
2.1
1.3
0.63
25
124
(40761535) Cells panel - Urine sediment
24
93
2.80
4.68
5.5
3.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
73
464
1.92
4.39
3.1
2.2
nmol/l
75.9
75.6
0.04
65
394
(3011397) Hemoglobin [Presence] in Urine by Test strip
45
262
1.93
3.43
5.2
4.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
21
91
2.47
3.31
3.5
6.9
mmol/l
25.2
24.1
0.67
21
86
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
7
8.79
3.28
1.5
2.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
27
132
2.21
3.26
3.6
2.8
ug/l
4.2
6.5
0.65
18
111
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
31
161
2.10
3.22
9.8
9.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
60
392
1.77
3.16
2.3
2.1
u/l
212.1
276.7
0.34
55
361
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7
12
6.00
3.05
3.1
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
95
2.36
3.02
1.7
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
13
5.54
2.89
3.1
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
21
97
2.31
2.89
3.5
4.0
—
—
—
0
0
(3012544) pH of Venous blood
24
120
2.14
2.75
10.5
4.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
78
566
1.63
2.72
6.3
4.4
g/l
34.8
34.9
0.06
69
524
(3042936) Bacteria identified in Isolate by Culture
34
195
1.90
2.69
2.9
1.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
58
391
1.69
2.68
5.8
4.0
mg/mmol
14.9
11.5
0.21
42
242
(3002032) Base excess in Venous blood by calculation
23
116
2.11
2.58
10.7
4.1
mmol/l
0.6
1.8
1.12
17
85
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
83
622
1.58
2.49
14.1
6.6
mmol/l
1.2
1.2
0.33
71
514
(3021447) Carbon dioxide [Partial pressure] in Venous blood
23
118
2.08
2.48
11.0
4.1
kpa
5.7
5.7
0.11
23
111
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
0
64
0.00
2.47
0.0
1.1
—
99.4
—
0
21
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
11
41
2.78
2.32
3.5
2.1
u/ml
0.3
0.3
—
6
23
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
66
2.38
2.31
2.9
7.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
20
100
2.11
2.30
9.2
2.9
kpa
5.0
4.3
0.95
20
93
(3019150) Specific gravity of Urine by Refractometry
43
278
1.70
2.30
4.5
4.5
kg/l
1.0
1.0
—
10
40
(3018418) pH of Serum or Plasma
54
374
1.61
2.21
8.6
3.9
ph
7.4
7.4
—
9
81
(3009508) Creatinine [Moles/volume] in Urine
56
393
1.60
2.17
4.9
3.0
mmol/l
6.0
7.6
2.64
45
311
(1761868) Lipid panel - Serum or Plasma
26
426
0.55
2.14
3.6
3.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
28
2.93
1.88
2.3
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
35
226
1.67
1.88
2.3
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
81
2.06
1.80
3.7
3.2
ml/min/173m2
75.3
64.9
—
6
33
(3012516) Albumin [Mass/volume] in Urine
52
374
1.53
1.79
5.2
3.1
mg/l
38.3
242.8
0.64
37
241
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
15
75
2.08
1.75
7.7
3.9
mmol/l
25.5
24.6
0.49
15
75
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
13
3.92
1.72
3.2
2.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
73
568
1.46
1.71
12.2
5.5
mmol/l
1.2
1.2
0.59
65
512
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
25
2.86
1.66
1.6
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
14
3.64
1.62
1.2
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
14
3.64
1.62
1.8
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
14
3.64
1.62
1.6
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
14
3.64
1.62
1.0
1.6
u/l
9.6
16.7
—
5
14
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
15
3.39
1.53
1.8
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
15
3.39
1.53
1.8
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
15
3.39
1.53
1.8
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
16
3.18
1.44
1.0
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
16
3.18
1.44
1.8
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
16
3.18
1.44
1.0
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
16
3.18
1.44
1.8
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
60
2.07
1.41
2.4
2.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
66
520
1.41
1.41
2.3
1.9
pmol/l
89.2
92.9
0.29
36
250
(3028626) Oxygen [Partial pressure] in Capillary blood
7
29
2.46
1.40
2.7
2.3
kpa
8.5
7.7
—
7
24
(3023368) Bacteria identified in Blood by Culture
54
414
1.42
1.33
4.5
4.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
24
2.55
1.31
1.5
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
17
100
1.77
1.28
12.0
7.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
109
1232
0.74
1.27
6.1
5.0
mmol/l
2.4
2.6
1.02
103
1102
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
56
2.02
1.24
2.4
1.8
—
—
—
0
0
(3020891) Body temperature
10
50
2.05
1.18
3.8
4.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
71
581
1.35
1.18
4.8
4.3
ng/l
36.5
55.0
1.00
55
431
(3017732) Neutrophils [#/volume] in Blood
14
80
1.81
1.16
2.8
2.5
e9/l
4.4
3.8
—
7
60
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
59
470
1.37
1.16
5.0
3.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
20
2.54
1.16
1.0
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
40
2.04
1.13
1.4
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
31
2.30
1.11
1.0
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
19
121
1.63
1.10
2.9
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
26
180
1.51
1.07
4.4
2.4
%
17.1
21.4
1.19
21
156
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
24
340
0.66
1.07
2.5
2.9
ug/l
0.8
0.8
0.11
16
227
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
33
2.16
1.06
1.0
1.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
46
357
1.38
1.05
2.8
2.0
mg/l
3.1
3.4
0.62
37
304
(3026008) Bacteria identified in Urine by Culture
51
403
1.36
1.05
2.9
3.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
38
286
1.41
1.04
2.2
1.8
nmol/l
1160.3
1214.7
0.16
32
215
(3003327) Ova and parasites identified in Stool by Light microscopy
5
22
2.30
1.04
1.0
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
90
774
1.30
1.03
7.3
4.5
mmol/l
7.8
6.8
2.60
83
722
(3035350) Ketones [Presence] in Urine by Test strip
72
602
1.31
1.01
4.7
3.9
estimate
0.0
0.0
—
9
121
(3015377) Calcium [Moles/volume] in Serum or Plasma
55
443
1.34
1.00
3.2
3.1
mmol/l
2.3
2.3
0.53
42
374
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
22
150
1.53
0.98
2.1
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
39
299
1.38
0.96
3.6
2.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
72
606
1.30
0.95
6.9
5.2
estimate
0.0
0.0
—
9
119
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
104
1160
0.78
0.95
5.2
4.0
mmol/l
1.4
1.3
1.42
93
1029
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
27
2.26
0.94
1.7
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
55
1.86
0.94
1.6
2.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
73
617
1.29
0.94
4.9
3.9
estimate
0.0
0.0
—
9
116
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
114
0.51
0.86
1.8
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
22
155
1.47
0.85
2.1
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
6
115
0.51
0.85
5.7
3.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
31
1.96
0.85
2.8
2.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
108
1190
0.79
0.84
5.7
4.4
mmol/l
1.3
1.4
1.20
97
1061
(3009542) Hematocrit [Volume Fraction] of Blood
119
1080
1.26
0.82
25.7
16.1
%
36.9
39.6
1.10
64
720
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
109
1198
0.80
0.82
5.7
4.5
mmol/l
4.3
4.5
0.90
99
1082
(3003338) MCHC [Mass/volume]
111
1001
1.25
0.80
29.2
20.1
g/l
332.4
332.3
0.05
111
990
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
48
1.69
0.79
1.9
2.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
0
25
0.00
0.79
0.0
1.0
—
0.7
—
0
20
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
26
0.00
0.79
0.0
3.0
—
4.4
—
0
26
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
27
0.00
0.78
0.0
3.6
—
58.6
—
0
27
(3041096) Erythrocytes [Presence] in Urine by Automated
28
363
0.73
0.77
4.0
3.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
99
886
1.24
0.75
4.2
3.6
pmol/l
15.2
15.0
0.19
87
766
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
108
976
1.24
0.75
8.0
7.0
u/l
91.0
79.9
0.51
103
911
(3000330) Specific gravity of Urine by Test strip
10
60
1.70
0.73
4.4
4.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
25
2.03
0.73
3.4
2.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
39
474
0.78
0.68
5.2
4.4
%
24.3
22.0
0.41
25
236
(3022313) Gas panel - Capillary blood
11
70
1.61
0.66
8.9
3.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
34
272
1.30
0.65
1.7
1.6
mg/l
1.7
1.4
0.42
27
205
(3000492) Spirometry study
6
104
0.56
0.64
1.3
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
52
606
0.81
0.63
4.6
5.0
ug/l
7.0
2.8
0.40
46
526
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
111
1200
0.83
0.63
5.3
4.6
mmol/l
6.6
6.1
1.93
97
1063
(3029937) Albumin [Presence] in Urine by Test strip
43
357
1.26
0.63
4.6
4.1
estimate
0.0
0.0
—
8
112
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
13
88
1.51
0.62
1.5
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
30
1.68
0.62
1.6
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
54
463
1.23
0.60
5.1
3.6
e6/l
47.5
94.2
0.70
42
341
(3022217) INR in Platelet poor plasma by Coagulation assay
24
185
1.34
0.59
33.9
24.8
inr
1.9
1.2
—
5
19
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
73
1.54
0.57
1.9
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
55
1.47
0.57
1.6
2.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
109
1171
0.84
0.53
19.7
14.8
ml/min/173m2
69.4
76.4
1.65
88
948
(3004588) Protein electrophoresis panel - Serum or Plasma
14
100
1.43
0.53
1.4
2.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
47
544
0.82
0.53
10.7
10.0
e9/l
0.0
0.0
0.54
38
451
(3019225) pH of Specimen
17
127
1.37
0.51
12.6
4.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
18
136
1.36
0.51
3.1
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
46
1.54
0.49
4.4
4.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
7
48
1.48
0.47
2.4
3.4
mmol/l
4.0
4.1
—
7
43
(40768804) Tissue Pathology biopsy report
41
475
0.83
0.47
2.6
2.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
82
0.60
0.47
2.0
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
65
581
1.18
0.46
4.5
4.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
49
1.44
0.46
1.0
1.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
15
113
1.35
0.44
1.4
2.4
ug/g
151.6
153.8
—
7
92
(42529406) Shigella sp [Presence] in Stool by Culture
5
31
1.63
0.43
1.6
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
31
1.63
0.43
1.6
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
13
96
1.38
0.43
3.2
2.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
53
469
1.18
0.42
3.5
3.3
ng/l
2143.6
1830.7
0.18
45
384
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
5
32
1.58
0.42
1.2
1.5
—
0.1
—
0
12
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
56
498
1.17
0.42
4.9
4.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
18
141
1.30
0.42
2.0
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
17
0.00
0.41
0.0
1.9
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
17
0.00
0.41
0.0
3.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
34
1.48
0.40
1.2
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
35
1.44
0.39
1.4
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
21
170
1.26
0.39
5.4
2.7
%
1.6
1.8
0.55
16
149
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
25
207
1.24
0.39
3.5
2.7
e6/l
0.3
1.1
2.40
17
114
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
36
1.40
0.38
1.4
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
36
1.40
0.38
1.0
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
21
171
1.26
0.37
3.2
1.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
68
622
1.14
0.35
6.1
5.7
e9/l
0.2
0.2
0.29
60
555
(3037467) Urinalysis macro (dipstick) panel - Urine
93
870
1.13
0.34
6.5
4.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
40
353
1.17
0.33
4.2
2.9
—
—
—
0
0
(3002256) Pathology report gross observation
11
143
0.76
0.33
1.3
1.3
—
—
—
0
0
(3013512) EKG study
44
392
1.16
0.33
5.5
4.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
13
164
0.78
0.32
6.2
4.7
%
32.3
32.1
—
7
104
(3021879) Hepatitis B virus core Ab [Presence] in Serum
10
75
1.35
0.31
2.1
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
46
414
1.15
0.30
4.3
3.1
e6/l
15.4
63.1
1.46
41
322
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
72
671
1.12
0.27
3.9
5.7
umol/l
10.6
12.3
0.84
64
633
(3019198) Lymphocytes [#/volume] in Blood
66
614
1.11
0.26
6.1
5.6
e9/l
1.7
1.8
0.16
59
552
(3044640) Blood type and Crossmatch panel - Blood
45
410
1.13
0.25
3.6
2.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
23
199
1.18
0.25
3.7
2.9
e6/l
0.9
1.6
0.59
15
107
(3001604) Monocytes [#/volume] in Blood
64
596
1.11
0.24
6.1
5.5
e9/l
0.7
0.6
2.05
57
530
(3030467) Casts [#/volume] in Urine by Automated count
40
364
1.12
0.23
4.4
2.9
e6/l
0.2
0.4
0.37
34
275
(4010399)
10
79
1.28
0.23
1.3
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
32
287
1.14
0.22
3.5
2.5
e6/l
2.4
4.0
1.31
32
258
(3006315) Basophils [#/volume] in Blood
64
599
1.10
0.22
6.1
5.5
e9/l
0.0
0.0
0.89
57
535
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
128
1321
0.91
0.22
13.0
10.0
u/l
29.7
25.0
0.76
122
1260
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
3.7
—
57.3
—
0
11
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(4024509)
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
14
166
0.83
0.21
1.4
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
61
571
1.10
0.21
13.9
9.7
inr
1.3
1.4
0.13
15
171
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
12
0.00
0.21
0.0
2.2
—
32.3
—
0
12
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
5
43
1.17
0.21
1.4
4.7
—
3.9
—
0
6
(3034860) Kappa light chains.free [Mass/volume] in Serum
5
43
1.17
0.21
1.4
4.7
mg/l
49.4
241.4
—
5
35
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
5
43
1.17
0.21
1.4
4.7
mg/l
34.3
33.6
—
5
36
(4306422)
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.4
—
64.2
—
0
14
(3008295) Osmolality of Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
270.9
—
0
9
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
15
127
1.20
0.20
1.1
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
111
1149
0.92
0.19
9.2
6.1
mmol/mol
44.7
41.2
2.22
101
1053
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
114
1101
1.09
0.19
5.3
4.3
mu/l
2.1
2.0
0.39
105
960
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
52
1.16
0.19
1.5
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
10
81
1.25
0.19
1.2
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
44
408
1.10
0.18
6.8
4.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
91
1.22
0.18
1.0
1.8
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
7
62
1.13
0.17
1.6
3.3
u/ml
12.0
3125.7
—
7
54
(3028026) IgM [Mass/volume] in Serum or Plasma
5
68
0.73
0.17
2.0
1.5
g/l
1.2
1.0
—
5
63
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
8
68
1.18
0.17
3.8
1.7
g/l
1.8
1.5
—
8
58
(3019832) Treponema pallidum Ab [Presence] in Serum
8
71
1.13
0.16
2.1
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
17
149
1.15
0.16
1.2
1.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
10
119
0.83
0.16
1.8
2.0
nmol/l
303.7
394.5
—
10
104
(3026493) Urate [Moles/volume] in Serum or Plasma
37
343
1.10
0.15
3.2
2.9
umol/l
26576.0
8005.5
0.49
31
281
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
70
671
1.07
0.13
3.2
2.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
128
1251
1.07
0.13
24.8
15.6
mg/l
27.8
25.8
0.25
111
1030
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
33
307
1.09
0.13
1.7
1.9
pmol/l
378.2
430.3
0.42
26
254
(3012095) Magnesium [Moles/volume] in Serum or Plasma
22
200
1.11
0.13
3.4
3.2
mmol/l
0.8
0.8
0.00
22
180
(3003694) ABO and Rh group [Type] in Blood
28
301
0.92
0.11
1.5
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
22
202
1.10
0.11
1.5
1.4
g/l
2.8
2.8
—
9
122
(3023103) Potassium [Moles/volume] in Serum or Plasma
133
1308
1.05
0.09
30.5
18.2
mmol/l
4.0
4.0
0.43
126
1257
(3025941) Bacteria identified in Stool by Culture
5
60
0.83
0.08
1.2
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
7
64
1.10
0.08
3.1
2.6
pmol/l
4.0
4.5
—
7
55
(3013707) Erythrocyte sedimentation rate by Westergren method
93
911
1.04
0.07
5.1
4.0
mm/h
19.6
13.4
1.47
81
825
(3019550) Sodium [Moles/volume] in Serum or Plasma
132
1303
1.04
0.06
30.2
18.2
mmol/l
139.7
139.5
0.42
126
1256
(40761511) CBC panel - Blood by Automated count
129
1306
0.96
0.06
24.4
14.9
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
137
1385
0.96
0.05
33.5
22.4
e12/l
4.4
4.5
0.60
132
1332
(3010813) Leukocytes [#/volume] in Blood
137
1385
0.96
0.05
33.7
22.4
e9/l
7.3
6.8
2.10
132
1334
(4035726)
11
120
0.91
0.05
1.5
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
25
258
0.96
0.02
3.9
6.1
—
—
—
0
0
(3044889) 12 lead EKG panel
87
878
0.98
0.01
4.2
4.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
29
297
0.97
0.01
9.3
6.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
71
711
1.00
0.00
8.4
9.0
e9/l
5.0
4.2
2.13
62
618
(3017181) Myelocytes/100 leukocytes in Blood
11
113
0.97
0.00
2.2
4.5
%
0.6
1.0
—
5
45
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
16
155
1.04
0.00
2.5
3.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
15
152
0.99
0.00
1.0
1.3
u/ml
1.3
12.4
—
7
66
(3021960) Folate [Moles/volume] in Serum or Plasma
32
318
1.01
0.00
1.6
1.5
nmol/l
18.6
20.6
0.29
25
256
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
12.6
—
0
6
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
107.2
—
0
6
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
19.9
—
0
6
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
219.8
—
0
6
(4211845)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
15.3
—
0
6
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
85
0.94
0.00
1.9
2.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(4281824)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
7
0.00
0.00
0.0
1.9
—
2550.0
—
0
7
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
31.0
—
0
7
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
20.0
—
0
5
(3000012) Reticulocyte production index
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
73
0.96
0.00
1.9
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
9
0.00
0.00
0.0
2.3
—
4.1
—
0
9
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
13.0
—
0
5
(3023511) Choriogonadotropin [Units/volume] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
6.5
—
0
7
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
257.2
—
0
5
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
102.4
—
0
5
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
85.8
—
0
5
(3005322) IgE [Units/volume] in Serum or Plasma
6
60
1.00
0.00
1.3
1.2
u/ml
31.4
280.3
—
6
55
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H7_GLOBEDEGENERATED and mortality.

Females

Parameter HR [95% CI] p-value
H7_GLOBEDEGENERATED 1.333 [1.16, 1.54] < 0.001
Birth year 0.996 [0.99, 1.0] 0.296

During the follow-up period (1.1.1998 — 31.12.2019), 733 out of 1161 females with H7_GLOBEDEGENERATED died.

Males

Parameter HR [95% CI] p-value
H7_GLOBEDEGENERATED 1.488 [1.24, 1.78] < 0.001
Birth year 0.988 [0.98, 1.0] 0.011

During the follow-up period (1.1.1998 — 31.12.2019), 564 out of 1066 males with H7_GLOBEDEGENERATED died.

Mortality risk

Mortality risk for people of age

years, who have H7_GLOBEDEGENERATED.

N-year risk Females Males
1 0.104% 0.31%
5 0.751% 1.805%
10 1.846% 4.363%
15 3.805% 8.382%
20 6.9% 14.242%

Relationships between endpoints

↥

Index endpoint: H7_GLOBEDEGENERATED – Degenerative conditions of globe

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data